Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure

Breast Cancer Research and Treatment

Volumn 118, Issue 2, 2009, Pages 385-394

  Montagna, E ^a   Viale, G ^a,b   Rotmensz, N ^a   Maisonneuve, P ^a   Galimberti, V ^a   Luini, A ^a   Intra, M ^a   Veronesi, P ^a,b   Mazzarol, G ^a,b   Pruneri, G ^a,b   Renne, G ^a,b   Torrisi, R ^a   Cardillo, A ^a   Cancello, G ^a   Goldhirsch, A ^a   Colleoni, M ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast cancer; Lymph node; Micrometastasis

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; HUMAN TISSUE; LOG RANK TEST; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SYSTEMIC THERAPY; TUMOR CELL;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 70350227044     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0446-6     Document Type: Article

References (24)

1. M Colleoni N Rotmensz G Perruzzotti, et al. 2005 Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement J Clin Oncol 23 1379 1389 10.1200/JCO.2005.07.094 15735114 (Pubitemid 46260025)
2. International (Ludwig) Breast Cancer Study Group 1990 Prognostic importance of occult axillary lymph node micrometastases from breast cancer Lancet 335 1565 1568
3. PT Truong V Vinh-Hung G Cserni, et al. 2008 The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer Eur J Cancer 44 12 1670 1677 10.1016/j.ejca.2008.05.011 18595686
4. SL Chen FM Hoehne 2007 The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis Ann Sur Oncol 14 12 3378 3384 10.1245/s10434-007-9513-6 (Pubitemid 350160103)
5. M van der Heiden-van der Loo PD Bezemer A Hennipman, et al. 2006 Introduction of sentinel node biopsy and stage migration of breast cancer Eur J Surg Oncol 32 710 714 10.1016/j.ejso.2006.04.001 1:STN:280: DC%2BD28rhtV2ltA%3D%3D 16765560 (Pubitemid 44276004)
6. MC van Rijk JL Peterse OE Nieweg, et al. 2006 Additional axillary metastases or submicrometastases in sentinel lymph nodes Cancer 107 3 467 471 10.1002/cncr.22069 16804924 (Pubitemid 44107205)
7. VC Tjan-Heijnen P Bult LM de Widt-Evert, et al. 2001 Micro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure Breast Cancer Res Treat 70 2 81 88 10.1023/A:1012938825396 1:STN:280: DC%2BD38%2Fkt1CrsQ%3D%3D 11768607 (Pubitemid 33139665)
8. U Veronesi G Paganelli V Galimberti, et al. 1997 Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes Lancet 349 1864 1867 10.1016/S0140-6736(97)01004-0 1:STN:280: DyaK2szmtVOqtg%3D%3D 9217757 (Pubitemid 27270119)
9. CW Elston IO Ellis 2002 Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer-Experience from a large study with long-term follow-up Histopathology 41 151 10.1046/j.1365-2559.2002. 14691.x 1:STN:280:DC%2BD38nkslWrtg%3D%3D 12405945 (Pubitemid 41713015)
10. Rosen PP, Oberman H (1993) Tumors of the mammary gland. Armed Forces Institute of Pathology, Washington
11. M Colleoni E Orvieto F Nolè, et al. 1999 Prediction of response to primary chemotherapy for operable breast cancer Eur J Cancer 35 574 579 10.1016/S0959-8049(99)00005-2 1:STN:280:DyaK1Mvit1aqug%3D%3D 10492630 (Pubitemid 29192965)
12. SE Singletary C Allred P Ashley, et al. 2002 Revision of the American Joint Committee on cancer staging system for breast cancer J Clin Oncol 20 3628 3636 10.1200/JCO.2002.02.026 12202663 (Pubitemid 34983222)
13. U Veronesi G Paganelli G Viale, et al. 2003 A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546 553 10.1056/NEJMoa012782 12904519 (Pubitemid 36951366)
14. R Gennari G Curigliano N Rotmensz, et al. 2004 Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients Cancer 101 1302 1310 10.1002/cncr.20535 15316944 (Pubitemid 39180385)
15. A Goldhirsch WC Wood HJ Senn, et al. 1995 Meeting highlights: International Consensus Panel on the treatment of primary breast cancer J Natl Cancer Inst 87 1441 1445 10.1093/jnci/87.19.1441 1:STN:280:DyaK2MvgsVKntg%3D%3D 7674331
16. A Goldhirsch JH Glick RD Gelber, et al. 1998 Meeting highlights: International consensus panel on the treatment of primary breast cancer J Natl Cancer Inst 90 1601 1608 10.1093/jnci/90.21.1601 1:STN:280: DyaK1M%2FislCnug%3D%3D 9811309
17. M Colleoni HJ Liman M Castiglione-Gertsch, et al. 2002 Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF Br J Cancer 86 1705 1714 10.1038/sj.bjc.6600334 1:CAS:528:DC%2BD38XkvVait7Y%3D 12087454 (Pubitemid 34712912)
18. B Fisher AM Brown NV Dimitrov, et al. 1990 Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B 15 J Clin Oncol 8 1483 1496 1:STN:280:DyaK3czmt1Wltg%3D%3D 2202791
19. AG Huvos R Hutter 1971 Significance of axillary macrometastases and micrometastases in mammary cancer Ann Surg 173 44 46 10.1097/00000658-197101000- 00006 1:STN:280:DyaE3M7htFWjug%3D%3D 5543548
20. O Saphir GD Amromin 1948 Obscure axillary lymph node metastases in carcinoma of the breast Cancer 1 238 241 10.1002/1097-0142(194807)1:2<238:: AID-CNCR2820010208>3.0.CO;2-U 1:STN:280:DyaH1c%2FhvVOrsQ%3D%3D 18875036
21. PJ Hainsworth JJ Tjandra RG Stillwell, et al. 1993 Detection and significance of occult metastases in node negative breast cancer Br J Surg 80 459 463 10.1002/bjs.1800800417 1:STN:280:DyaK3s3msFartg%3D%3D 8388305
22. MN Hansen BJ Grube W Te, et al. 2001 Clinical significance of axillary micrometastases in breast cancer: how small is too small? Proc Am Soc Clin Oncol 20 24 abstr 91
23. De Boer M, van Deurzen CH, van Dijck JA et al. (2009) Micrometastases and isolated tumors cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists group (BOOG). Cancer Res 69(Suppl 2):70s abstr 23
24. PD Gobardhan SG Elias EVE Madsen, et al. 2009 Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study Ann Oncol 20 1 41 48 10.1093/annonc/mdn535 1:STN:280: DC%2BD1M%2Fns1ymsw%3D%3D 18653702